Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-28 Option Award | 2024-08-05 6:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,363 | $9.945 | 185,083 (Direct) | View |
2024-08-01 Option Award | 2024-08-05 6:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 58,867 | $0 | 185,083 (Direct) | View |
2023-06-30 Option Award | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,123 | $16.99 | 185,903 (Direct) | View |
2024-01-02 Tax Withholding | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 8,410 | $17.95 | 185,903 (Direct) | View |
2022-06-30 Option Award | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 728 | $21 | 185,903 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:22 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 99,512 | $0 | 185,903 (Direct) | View |
2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 2,058 | $22.68 | 145,936 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 118,916 | $0 | 145,936 (Direct) | View |
2021-12-31 Option Award | 2022-01-04 9:04 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1 | $27.8 | 80,178 (Direct) | View |
2022-01-01 Tax Withholding | 2022-01-04 9:04 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,221 | $32.7 | 80,178 (Direct) | View |
2021-06-30 Option Award | 2022-01-04 9:04 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 555 | $33.02 | 80,178 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 9:04 pm | N/A 2032-01-03 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 61,800 | $0 | 80,178 (Direct) | View |
2020-06-30 Option Award | 2021-01-06 08:53 am | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 641 | $31.31 | 71,543 (Direct) | View |
2019-12-31 Option Award | 2021-01-06 08:53 am | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 302 | $34.82 | 71,543 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 08:53 am | N/A 2031-01-04 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 64,100 | $0 | 71,543 (Direct) | View |
2020-01-02 Option Award | 2020-01-06 4:23 pm | N/A 2030-01-02 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 48,000 | $0 | 48,000 (Direct) | View |